HCWB icon

HCW Biologics
HCWB

10 hedge funds and large institutions have $457K invested in HCW Biologics in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$309K
2
+$57.1K
3
+$40.7K
4
TRCT
Tower Research Capital (TRC)
New York
+$4.85K
5
Citigroup
Citigroup
New York
+$1.15K

Top Sellers

1
-$37.7K
2
-$230
3
-$20
Name Holding Trade Value Shares
Change 		Change in
Stake
DS
1
DRW Securities
Illinois
$309K
Vanguard Group
2
Vanguard Group
Pennsylvania
$57.1K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$40.7K
GSWM
4
Golden State Wealth Management
California
$37K
Wells Fargo
5
Wells Fargo
California
$6.29K
TRCT
6
Tower Research Capital (TRC)
New York
$5.78K
Citigroup
7
Citigroup
New York
$1.15K
Osaic Holdings
8
Osaic Holdings
Arizona
$96
Bank of America
9
Bank of America
North Carolina
$37
SS
10
SBI Securities
Japan
$4
UBS Group
11
UBS Group
Switzerland
–
FFO
12
Fortitude Family Office
Arizona
–